Qingdao Guoda Biopharmaceutical

Qingdao Guoda Biopharmaceutical is a China-based pharmaceutical manufacturer focused on the development, production, and sale of biochemical drugs and oral formulations. Public corporate registry sources indicate the company remains active and manufactures lyophilized injectable products, active pharmaceutical ingredients, and biopharmaceutical products. Its disclosed commercial portfolio includes lumbrokinase enteric-coated capsules marketed as Puenfu, as well as pefloxacin mesylate capsules, procaterol hydrochloride tablets, and flunarizine hydrochloride dispersible tablets. Registry records also list peptide and biochemical APIs including salmon calcitonin, somatostatin, thymopentin, and lumbrokinase. The company appears to operate primarily as a commercial-stage domestic drug manufacturer rather than a venture-backed innovative clinical biotech.